Shikha Rathi, MBBS, MD | |
7908 Bustleton Ave, Philadelphia, PA 19152-3303 | |
(215) 725-7401 | |
(215) 725-5827 |
Full Name | Shikha Rathi |
---|---|
Gender | Female |
Speciality | Rheumatology |
Experience | 16 Years |
Location | 7908 Bustleton Ave, Philadelphia, Pennsylvania |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093083552 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
St Mary Medical Center | Langhorne, PA | Hospital |
Hospital Of Univ Of Pennsylvania | Philadelphia, PA | Hospital |
Jefferson Heath | Philadelphia, PA | Hospital |
Lower Bucks Hospital | Bristol, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Arthritis Group Pc | 0042282360 | 7 |
News Archive
In a new Johns Hopkins study of patient and graft survival trends for pediatric liver transplant recipients between 2002 and 2015, researchers found that outcomes for alternatives to whole liver transplantation, such as splitting a liver for two recipients or using a part of a liver from a living donor, have improved significantly.
Climate change may progressively affect human health for the worse, requiring prompt and resolute action to stabilize it, reports a consortium of 27 leading scientific academies in Europe.
Emergent BioSolutions Inc. today announced its decision to expand the protocol for its ongoing Phase 1b, single arm, open label study (Protocol 16009) evaluating the safety and efficacy of TRU-016 in combination with rituximab in previously untreated patients with chronic lymphocytic leukemia.
mtm laboratories, a privately held diagnostics company developing, manufacturing and globally commercializing in vitro diagnostics for cervical cancer early detection and diagnosis, today announced the publication of a new paper showing that dual staining for p16 and Ki-67 can pinpoint the underlying high-grade cervical disease with a high degree of sensitivity and specificity in women with ASC-US or LSIL cytology results.
› Verified 1 days ago
Entity Name | Einstein Practice Plan Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1760434468 PECOS PAC ID: 2769395896 Enrollment ID: O20040219000728 |
News Archive
In a new Johns Hopkins study of patient and graft survival trends for pediatric liver transplant recipients between 2002 and 2015, researchers found that outcomes for alternatives to whole liver transplantation, such as splitting a liver for two recipients or using a part of a liver from a living donor, have improved significantly.
Climate change may progressively affect human health for the worse, requiring prompt and resolute action to stabilize it, reports a consortium of 27 leading scientific academies in Europe.
Emergent BioSolutions Inc. today announced its decision to expand the protocol for its ongoing Phase 1b, single arm, open label study (Protocol 16009) evaluating the safety and efficacy of TRU-016 in combination with rituximab in previously untreated patients with chronic lymphocytic leukemia.
mtm laboratories, a privately held diagnostics company developing, manufacturing and globally commercializing in vitro diagnostics for cervical cancer early detection and diagnosis, today announced the publication of a new paper showing that dual staining for p16 and Ki-67 can pinpoint the underlying high-grade cervical disease with a high degree of sensitivity and specificity in women with ASC-US or LSIL cytology results.
› Verified 1 days ago
Entity Name | Arthritis Group Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1700823838 PECOS PAC ID: 0042282360 Enrollment ID: O20040809000244 |
News Archive
In a new Johns Hopkins study of patient and graft survival trends for pediatric liver transplant recipients between 2002 and 2015, researchers found that outcomes for alternatives to whole liver transplantation, such as splitting a liver for two recipients or using a part of a liver from a living donor, have improved significantly.
Climate change may progressively affect human health for the worse, requiring prompt and resolute action to stabilize it, reports a consortium of 27 leading scientific academies in Europe.
Emergent BioSolutions Inc. today announced its decision to expand the protocol for its ongoing Phase 1b, single arm, open label study (Protocol 16009) evaluating the safety and efficacy of TRU-016 in combination with rituximab in previously untreated patients with chronic lymphocytic leukemia.
mtm laboratories, a privately held diagnostics company developing, manufacturing and globally commercializing in vitro diagnostics for cervical cancer early detection and diagnosis, today announced the publication of a new paper showing that dual staining for p16 and Ki-67 can pinpoint the underlying high-grade cervical disease with a high degree of sensitivity and specificity in women with ASC-US or LSIL cytology results.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Shikha Rathi, MBBS, MD 7908 Bustleton Ave, Philadelphia, PA 19152-3303 Ph: (215) 725-7401 | Shikha Rathi, MBBS, MD 7908 Bustleton Ave, Philadelphia, PA 19152-3303 Ph: (215) 725-7401 |
News Archive
In a new Johns Hopkins study of patient and graft survival trends for pediatric liver transplant recipients between 2002 and 2015, researchers found that outcomes for alternatives to whole liver transplantation, such as splitting a liver for two recipients or using a part of a liver from a living donor, have improved significantly.
Climate change may progressively affect human health for the worse, requiring prompt and resolute action to stabilize it, reports a consortium of 27 leading scientific academies in Europe.
Emergent BioSolutions Inc. today announced its decision to expand the protocol for its ongoing Phase 1b, single arm, open label study (Protocol 16009) evaluating the safety and efficacy of TRU-016 in combination with rituximab in previously untreated patients with chronic lymphocytic leukemia.
mtm laboratories, a privately held diagnostics company developing, manufacturing and globally commercializing in vitro diagnostics for cervical cancer early detection and diagnosis, today announced the publication of a new paper showing that dual staining for p16 and Ki-67 can pinpoint the underlying high-grade cervical disease with a high degree of sensitivity and specificity in women with ASC-US or LSIL cytology results.
› Verified 1 days ago
Philippe Olivier Szapary, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 3400 Civic Center Blvd, East Pavilion, 2nd Floor, Philadelphia, PA 19104 Phone: 215-615-4949 | |
Dr. Jamie L. Garfield, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3401 N Broad St, Philadelphia, PA 19140 Phone: 215-707-5864 Fax: 215-707-6867 | |
Maria Esther Escorcia De Leon, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3401 N Broad St, Philadelphia, PA 19140 Phone: 215-707-1622 Fax: 215-707-0943 | |
Cherag Daruwala, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2301 E Allegheny Ave, Suite 190b, Philadelphia, PA 19134 Phone: 215-926-3120 Fax: 215-926-3123 | |
Dr. Robert Burke, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 51 N 39th St, Philadelphia, PA 19104 Phone: 215-662-9436 Fax: 215-243-3208 | |
Eva Hassan Alsheik, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 219 N Broad St, 5th Floor, Philadelphia, PA 19107 Phone: 215-762-6071 | |
Dr. Jason Thomas Ackrivo, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3400 Spruce St, Philadelphia, PA 19104 Phone: 215-614-0871 |